1. Home
  2. PD vs SGP Comparison

PD vs SGP Comparison

Compare PD & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$8.70

Market Cap

782.0M

Sector

Technology

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$18.55

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PD
SGP
Founded
2009
2019
Country
United States
United States
Employees
N/A
65
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.0M
650.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PD
SGP
Price
$8.70
$18.55
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$12.63
$45.00
AVG Volume (30 Days)
2.1M
39.5K
Earning Date
05-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
0.13
N/A
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
N/A
Revenue Next Year
$2.88
N/A
P/E Ratio
$67.46
N/A
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$17.60
52 Week High
$17.45
$30.56

Technical Indicators

Market Signals
Indicator
PD
SGP
Relative Strength Index (RSI) 56.07 32.86
Support Level $6.08 $17.60
Resistance Level $16.74 $26.29
Average True Range (ATR) 0.56 1.42
MACD 0.06 -0.12
Stochastic Oscillator 50.24 15.72

Price Performance

Historical Comparison
PD
SGP

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: